Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds advantageous in the treatment of central nervous system diseases and disorders

Compounds advantageous in the treatment of central nervous system diseases and disorders

US Patent 12486218 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds advantageous in the treatment of central nervous system diseases and d2020
Compounds advantageous in the treatment of central nervous system diseases and d2020
Compounds advantageous in the treatment of central nervous system diseases and d2015
Compounds advantageous in the treatment of central nervous system diseases and d2015
Compounds advantageous in the treatment of central nervous system diseases and d2015
Methods to manufacture 1,3-dioxolane nucleosides2013
Methods to manufacture 1,3-dioxolane nucleosides2010
Treating a variety of pathological conditions, including spasticity and convulsi2007
Inorganic ion receptor-active compounds2004
Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamide2003
Treating a variety of pathological conditions, including spasticity and convulsi2003
Compositions comprising valerian extracts, isovaleric acid or derivatives thereo2002